Skip to main content
HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
17.36
-0.32 (-1.81%)
Nov 22, 2024, 4:00 PM EST - Market closed

HUTCHMED (China) Revenue

HUTCHMED (China) had revenue of $305.68M in the half year ending June 30, 2024, with 51.29% growth. This brings the company's revenue in the last twelve months to $610.81M, down -19.34% year-over-year. In the year 2023, HUTCHMED (China) had annual revenue of $838.00M with 96.52% growth.

Revenue (ttm)
$610.81M
Revenue Growth
-19.34%
P/S Ratio
n/a
Revenue / Employee
$307,246
Employees
1,988
Market Cap
2.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020227.98M23.09M11.27%
Dec 31, 2019204.89M-9.22M-4.31%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 9.47B
Surgery Partners 2.99B
Amedisys 2.32B
Veracyte 425.33M
Vericel 226.84M
Kymera Therapeutics 87.56M
Merus 35.93M
Revenue Rankings

HCM News

More News